- Home
- CENX vs CLDX Comparison
CENX vs CLDX Comparison
Compare CENX & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CENX | CLDX |
|---|---|---|
| Founded | 1995 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aluminum | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.0B |
| IPO Year | 2004 | 1995 |
Fundamental Metrics
Financial Performance| Metric | CENX | CLDX |
|---|---|---|
| Price | $36.53 | $30.24 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 15 |
| Target Price | ★ $65.25 | $63.07 |
| AVG Volume (30 Days) | 1.5M | ★ 2.0M |
| Earning Date | 11-05-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.62 | N/A |
| Revenue | ★ $1,893,200,000.00 | $12,743,000.00 |
| Revenue This Year | $32.99 | $19.74 |
| Revenue Next Year | $23.69 | $438.11 |
| P/E Ratio | $6.47 | ★ N/A |
| Revenue Growth | N/A | ★ 87.78 |
| 52 Week Low | $25.40 | $22.10 |
| 52 Week High | $70.43 | $45.14 |
Technical Indicators
Market Signals| Indicator | CENX | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 35.20 | 31.16 |
| Support Level | $35.04 | $28.82 |
| Resistance Level | $47.34 | $31.80 |
| Average True Range (ATR) | 1.13 | 2.10 |
| MACD | 0.05 | -0.25 |
| Stochastic Oscillator | 30.31 | 11.73 |
Price Performance
Historical ComparisonAbout CENX Century Aluminum Company
Century Aluminum Co produces primary aluminum standard grade and value-added products. The firm operates smelter facilities in the United States and Iceland. The majority of revenue is generated from Glencore, which agreed to purchase nearly all of Century Aluminum's North American production. The company produces high purity aluminum, standard-grade aluminum sow and tee bars, and value-added billet and foundry products. The company also owns a carbon anode production facility in the Netherlands.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.